凝聚脂质包被全氟化碳纳米液滴的体外与体内行为评估
研究制备全氟丁烷纳米液滴(NDs),在体外表征其粒径分布、气核含量、血液稳定性及声致汽化行为,并在大鼠静脉推注后首次联合超声造影成像、气相色谱-质谱和荧光强度三种方法评估其体内持久性。结果显示NDs循环时间较临床获批微泡更长,三种监测方法所得半衰期仅轻微差异,汽化后肝脾局灶回声信号与荧光纳米液滴蓄积一致。
要点
- 全氟丁烷纳米液滴经冷凝制备后粒径分布发生偏移,Coulter Counter Multisizer结果证实。
- 纳米液滴循环时间较临床获批微泡更长,三种监测方法所得半衰期仅轻微差异。
- 汽化后肝脾局灶回声信号与荧光纳米液滴蓄积一致,提示可在这些器官聚集。
核心结论
- 研究增进了对声响应纳米液滴体外与体内行为的理解,作者认为这是实现有效临床转化的关键。
研究设计与样本
- 体外制备全氟丁烷纳米液滴并进行表征,同时在大鼠静脉推注后开展体内评估,采用超声造影成像、气相色谱-质谱和荧光强度测量三种互补检测方法。
关键影像表现/征象
- 汽化后在肝脏和脾脏局灶区域观察到回声信号,并经荧光纳米液滴在这些器官的蓄积所证实。
- Coulter Counter Multisizer结果证实冷凝后粒径分布发生偏移。
诊断标准与关键数值
- 微泡与纳米液滴悬液获得相似的全氟丁烷浓度,提示微泡破裂和纳米液滴自发汽化率极低。
- 纳米液滴循环时间较临床获批微泡更长,三种监测方法之间仅观察到半衰期的轻微差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Phase-shift contrast agents consist of a liquid perfluorocarbon core that can be vaporized by ultrasound to generate echogenic contrast with excellent spatiotemporal control. The purpose of the present work was to evaluate the in vitro and in vivo behavior of condensed lipid-shelled nanodroplets (NDs) using different analytical procedures.
METHODS: Perfluorobutane NDs were prepared by condensation of precursor fluorescently labeled lipid-shelled microbubbles (MBs) and were characterized in terms of size distribution, gas core content and in vitro stability in blood, as well as for their acoustic vaporization behavior using a custom-made setup. In particular, the in vivo behavior of the NDs was thoroughly investigated after intravenous bolus injection in rats. To this end, we report, for the first time, the efficient use of three complementary detection procedures to assess the in vivo persistence of NDs: (i) ultrasound contrast imaging of vaporized NDs, (ii) gas chromatography-mass spectrometry to determine the perfluorobutane core content and (iii) fluorescence intensity measurement in the collected blood samples.
RESULTS: The Coulter Counter Multisizer results confirmed the size distribution shift post-condensation. Furthermore, similar PFB concentrations from MB and ND suspensions were obtained, indicating an exceptionally low rate of MB breakage and spontaneous nanodroplet vaporization. As expected, these nanoscale droplets have longer circulation times compared with clinically approved MBs, and only slight variations in half-life were observed between the three monitoring procedures. Finally, echogenic signal observed in focal areas of the liver and spleen after vaporization was confirmed by accumulation of fluorescent nanodroplets in these organs.
CONCLUSION: These results further contribute to our understanding of both the in vitro and in vivo behavior of sono-responsive nanodroplets, which is key to enabling efficient clinical translation.
引用
- Melich R, Emmel P, Vivien A, et al. In Vitro and In Vivo Behavioral Evaluation of Condensed Lipid-Coated Perfluorocarbon Nanodroplets. Ultrasound Med Biol. 2024. PMID: 38637170. doi:10.1016/j.ultrasmedbio.2024.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。